Biotechnology on Drugs

Biotechnology has traded basically sideways since the start of 2023. In the face of higher rates, stronger dollar, inflation, FDA approvals and busts,

Are You Ready for a Huge Selloff?

We first saw the mega-cap technology names rotate lower, with Apple (AAPL) and Microsoft (MSFT) breaking down after clear bearish divergences. We now